Piastra V, Pranteda A, Bossi G
Cancers (Basel). 2022; 14(3).
PMID: 35158751
PMC: 8833818.
DOI: 10.3390/cancers14030483.
Amin M, Trevelyan C, Turner N
Cells. 2021; 10(12).
PMID: 34943783
PMC: 8699121.
DOI: 10.3390/cells10123274.
Martinez-Morales P, Moran Cruz I, Roa-de la Cruz L, Maycotte P, Reyes Salinas J, Vazquez Zamora V
PeerJ. 2021; 9:e12081.
PMID: 34540372
PMC: 8415283.
DOI: 10.7717/peerj.12081.
Xu Z, Zhang Y, Ocansey D, Wang B, Mao F
Front Oncol. 2021; 11:706862.
PMID: 34485140
PMC: 8415776.
DOI: 10.3389/fonc.2021.706862.
Mitra T, Elangovan S
Mol Cell Biochem. 2021; 476(12):4363-4385.
PMID: 34453645
DOI: 10.1007/s11010-021-04249-4.
Rs884225 polymorphism is associated with primary hypertension by compromising interaction between epithelial growth factor receptor (EGFR) and miR-214.
Luo F, Wu Y, Ding Q, Yuan Y, Jia W
J Cell Mol Med. 2021; 25(8):3714-3723.
PMID: 33635564
PMC: 8051725.
DOI: 10.1111/jcmm.15976.
miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools.
Galvao-Lima L, Morais A, Valentim R, Barreto E
Biomed Eng Online. 2021; 20(1):21.
PMID: 33593374
PMC: 7885381.
DOI: 10.1186/s12938-021-00857-9.
Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
Li X, Zhang C, Tian Y
J Mol Histol. 2021; 52(2):245-256.
PMID: 33394293
DOI: 10.1007/s10735-020-09944-y.
Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review.
Szczepanek J
World J Clin Oncol. 2020; 11(6):348-369.
PMID: 32855905
PMC: 7426929.
DOI: 10.5306/wjco.v11.i6.348.
The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer.
Tornesello M, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A
Front Oncol. 2020; 10:150.
PMID: 32154165
PMC: 7044410.
DOI: 10.3389/fonc.2020.00150.
Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.
Sammarco M, Tamburro M, Pulliero A, Izzotti A, Ripabelli G
Microrna. 2019; 9(3):174-186.
PMID: 31738147
PMC: 7366004.
DOI: 10.2174/2211536608666191026115045.
MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells.
Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Rios-Colon L
Sci Rep. 2019; 9(1):9776.
PMID: 31278310
PMC: 6611815.
DOI: 10.1038/s41598-019-46170-3.
RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1).
Zhao X, Wang Q, Lin F, Wang X, Wang Y, Wang J
Med Sci Monit. 2019; 25:4982-4991.
PMID: 31276465
PMC: 6626500.
DOI: 10.12659/MSM.917375.
MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
Shan H, Zhou X, Chen C
Mol Med Rep. 2019; 20(2):1459-1467.
PMID: 31173203
PMC: 6625444.
DOI: 10.3892/mmr.2019.10325.
MicroRNA 214 inhibits adipocyte enhancer-binding protein 1 activity and increases the sensitivity of chemotherapy in colorectal cancer.
Li S, Li C, Fang Z
Oncol Lett. 2019; 17(1):55-62.
PMID: 30655737
PMC: 6313171.
DOI: 10.3892/ol.2018.9623.
microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2.
Yang Y, Liu Y, Li G, Li L, Geng P, Song H
Oncol Lett. 2018; 16(5):5679-5686.
PMID: 30344723
PMC: 6176260.
DOI: 10.3892/ol.2018.9363.
miR-214 targets the PTEN-mediated PI3K/Akt signaling pathway and regulates cell proliferation and apoptosis in ovarian cancer.
Liu J, Chen W, Zhang H, Liu T, Zhao L
Oncol Lett. 2017; 14(5):5711-5718.
PMID: 29113199
PMC: 5661372.
DOI: 10.3892/ol.2017.6953.
Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC.
Cheng Q, Han L, Zhao H, Li H, Li J
Oncol Lett. 2017; 14(4):4605-4612.
PMID: 29085459
PMC: 5649611.
DOI: 10.3892/ol.2017.6819.
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Jiang W, Pan J, Deng Y, Liang M, Yao L
J Gynecol Oncol. 2017; 28(6):e75.
PMID: 29027393
PMC: 5641525.
DOI: 10.3802/jgo.2017.28.e75.
Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.
Koduru S, Leberfinger A, Ravnic D
J Genomics. 2017; 5:99-118.
PMID: 28943972
PMC: 5607708.
DOI: 10.7150/jgen.22060.